Hikma Pharmaceutical | HIK - Ordinary Share Capital

Stock Price
1,308.00
Daily Change
21.00 1.63%
Monthly
4.89%
Yearly
-33.09%
Q2 Forecast
1,279.62

Hikma Pharmaceutical reported $221.89M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Almirall EUR 214.79M 0 Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Autolus Therapeutics Ltd USD 266.14M 1.88K Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Fresenius EUR 563.24M 0 Sep/2025
Galapagos EUR 65.9M 0 Dec/2025
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GRIFOLS EUR 680.58M 846K Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Dec/2025
Orion EUR 140.69M 0 Sep/2025
Recordati EUR 205.83M 270K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 190.36M 365.15K Dec/2025